An Open-label 52-Week Safety Study of Bicifadine SR in Adult Outpatients with Chronic Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
100 项与 XTL Development, Inc. 相关的临床结果
0 项与 XTL Development, Inc. 相关的专利(医药)
100 项与 XTL Development, Inc. 相关的药物交易
100 项与 XTL Development, Inc. 相关的转化医学